The use of S100 proteins testing in juvenile idiopathic arthritis and autoinflammatory diseases in a pediatric clinical setting: A retrospective analysis.
Aljaberi, N; Tronconi, E; Schulert, G; Grom, AA; Lovell, DJ; Huggins, JL; Henrickson, M; Brunner, HI.
Pediatric Rheumatology Online Journal.
2020;
18.
Defining the scourge of COVID-19 hyperinflammatory syndrome.
Cron, RQ; Schulert, GS; Tattersall, RS.
2020;
2:e727-e729.
A novel STING1 variant causes a recessive form of STING-associated vasculopathy with onset in infancy (SAVI).
Lin, B; Berard, R; Al Rasheed, A; Aladba, B; Kranzusch, PJ; Henderlight, M; Grom, A; Kahle, D; Torreggiani, S; Aue, AG; et al.
Journal of Allergy and Clinical Immunology.
2020;
146:1204-1208.e6.
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 1.
Henderson, LA; Canna, SW; Friedman, KG; Gorelik, M; Lapidus, SK; Bassiri, H; Behrens, EM; Ferris, A; Kernan, KF; Schulert, GS; et al.
Arthritis and Rheumatology.
2020;
72:1791-1805.
The storm beneath the storm: MAS-HLH in inflammatory myopathies.
Schulert, GS.
The Journal of rheumatology.
2020;
47:1461-1463.
Can tocilizumab calm the cytokine storm of COVID-19?.
Schulert, GS.
2020;
2:e449-e451.
Proceedings from the 2ndNext Gen Therapies for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome symposium held on October 3-4, 2019.
Canna, SW; Schulert, GS; de Jesus, A; Pickering, A; Brunner, H; Gadina, M; Levine, S; Goldbach-Mansky, R; Boutelle, J; Sinha, R; et al.
Pediatric Rheumatology Online Journal.
2020;
18.
On the Alert for Cytokine Storm: Immunopathology in COVID-19.
Henderson, LA; Canna, SW; Schulert, GS; Volpi, S; Lee, PY; Kernan, KF; Caricchio, R; Mahmud, S; Hazen, MM; Halyabar, O; et al.
Arthritis and Rheumatology.
2020;
72:1059-1063.
The genetics of macrophage activation syndrome.
Schulert, GS; Cron, RQ.
Genes and Immunity.
2020;
21:169-181.
Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases.
de Jesus, AA; Hou, Y; Brooks, S; Malle, L; Biancotto, A; Huang, Y; Calvo, KR; Marrero, B; Moir, S; Oler, AJ; et al.
Journal of Clinical Investigation.
2020;
130:1669-1682.